Prematurity of Fetus Clinical Trial
Official title:
Pharmacokinetics of Oseltamivir in Newborns and Infants
Oseltamivir dosing in infants < 3 months of age is based on a single pharmacokinetic study in 20 infants from a single center. This dataset is limited by a lack of robustness, because only 1 sample was collected from each participant. The investigators obtained two blood samples each from infants receiving oseltamivir after obtaining informed consent from the infant's parents. The investigators propose to analyze the blood samples to determine the amount of oseltamivir in the infant's blood. Measurement of these values will increase the understanding of the absorption and elimination of oseltamivir in preterm and term infants, and improve our ability to provide the correct doses to this high risk population.
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01493063 -
LACTACOL 01 - Impact of Breast Milk on the Neurodevelopment of Preterm Newborns
|
||
Completed |
NCT00817921 -
Effect of Prematurity on Renal Function in 5 Years Old Children
|
N/A | |
Not yet recruiting |
NCT01305720 -
The Effect of Mydriatic Eye Drops on Cerebral and Mesenteric Oxygenation in Preterm Infants
|
Phase 4 | |
Completed |
NCT01300130 -
Investigations on Improving Docosahexaenoic and Arachidonic Acid Content in Preterm Infant Formula
|
N/A | |
Active, not recruiting |
NCT01517828 -
Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room
|
Phase 3 | |
Completed |
NCT01428180 -
Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants
|
Phase 4 | |
Completed |
NCT01367015 -
Early Versus Late Initiation of Feeding in Premature Growth Restricted Newborns With Absent or Reversed End Diastolic Flow On Umbilical Artery Doppler (AREDF)
|
N/A |